DELPHI VENTURES VIII LP → TANDEM DIABETES CARE INC TNDM

Stake: — Shares: —

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 25/100

Passive Schedule 13G filer baseline
Held by 1 tracked 13F institutional manager
Elevated short days-to-cover (6.9 DTC)
Short interest building (+12.8% vs prior settlement)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

3 transactions

1 buys · 0 sales · 2 awards/exercises

Issuer Cluster

3 13D/G filings on this issuer

2 other filings besides this one

Filer Track Record

2 filings by this filer

1 other filing in the data moat

Short Interest · settle 2026-10-15

DTC 6.86

15,086,560 shares short · +12.8% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $4.09M

Point72 Asset Mgmt

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-05-21	Allen Dick	—	Option exercise	8,759	—	—
2026-05-21	Allen Dick	—	Option exercise	8,759	—	—
2026-05-20	Allen Dick	—	Award	10,220	—	—

Other 13D/G Filings on TANDEM DIABETES CARE INC

Filed	Form	Filer	Stake	Shares
2018-02-16	SC	BLICKENSTAFF KIM D	—	—	view →
2018-01-09	SC	SABBY MANAGEMENT, LLC	—	—	view →

Other Filings by DELPHI VENTURES VIII LP

Filed	Form	Issuer	Stake	Shares
2020-02-07	SC	Calithera Biosciences, Inc.	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →